Impact of marital disparities in treatment and outcome in elderly patients with T1N0M0 small cell lung cancer Authors: Yahua Wu, Yingjiao Zhu, Lihu Lu, Bin Du, Rongqi Jiang, Jianping Zheng, Yaping Hong, Chengliu Lv, Na Yao, Jinhuo Lai Published: 2025 ABSTRACT AbstractBackgroundThis study aimed to investigate the impact of marital status on the treatment and survival of T1N0M0 elderly small cell lung cancer (SCLC) patients.MethodsAll elderly (≥ 70 years) patients with T1N0M0 SCLC were identified from the Surveillance Epidemiology and End Results (SEER) database (2000–2021). We performed univariate and multivariable cox analysis to identify prognostic factors associated with overall survival (OS) and cancer-specific survival (CSS). Propensity matching method (PSM) was used to equalise confounders between groups of different marital status.ResultsThere were 1391 elderly patients with early-stage SCLC included in the study. In multivariate analysis, gender, marital status, and receipt of surgery and chemotherapy were associated with OS, whereas age and receipt of surgery, chemotherapy, or radiotherapy were associated with CSS. After PSM, both median OS and CSS were lower in widowed patients compared with married patients. Subgroup analyses showed that among patients who were 70–79 years old, male, and did not receive surgery or radiotherapy, OS was significantly lower in widowed patients than in married patients, whereas among those who were ≥ 80 years, female, and received surgery or radiotherapy, there was no significant difference in OS between two groups. Similarly, among patients who were male or did not receive radiotherapy, the CSS of widowed patients was significantly lower than that of married patients, but no significant difference in CSS was observed between two groups among patients who were female or received radiotherapy.ConclusionsMarital status influenced survival in older patients with early-stage SCLC, especially in widowed individuals who were 70–79 years, male, and did not undergo surgery or radiotherapy.Keywords: Small cell lung cancer, Elderly, Marital status, SEER Introduction Lung cancer remains one of the leading causes of cancer-related deaths worldwide [1]. Small cell lung cancer (SCLC) is the histologic type with the worst prognosis, accounting for about 15% of all lung cancer cases [2]. The incidence of SCLC in the elderly is increasing every year due to the longer life expectancy. A large cohort from the Dutch Cancer Registry recorded 52,527 patients diagnosed with SCLC and showed that from 1989 to 2020, the proportion of patients ≥ 70 years increased from 38% to 46%, most notably in the 75 + group (20% up to 25%) [3]. Another retrospective study reported a median age of 69 years (interquartile range [IQR], 62–77 years) for patients diagnosed with SCLC in Victoria between 2011 and 2019 [4]. Obviously, SCLC is a major health issue for older adults. With the advancement of tumor screening methods, the incidence of early-stage elderly SCLC patients has been increasing yearly, but the prognosis is unsatisfactory. Therefore, it is important to urgently explore potential prognostic factors. Marital status, as one of the significant social factors, has gradually attracted widespread attention. Numerous studies have shown that marital status is strongly associated with the prognosis of cancer [5, 6]. Marital status affects patients’ medical adherence, especially in elderly patients. Married patients have better adherence compared to unmarried patients [6]. Patients with good compliance contribute to active treatment and a good prognosis. However, little has been reported on whether differences in marital status affect treatment and outcomes among elderly SCLC patients. Therefore, this study investigated the impact of marital disparities on the treatment and survival of early-stage elderly SCLC patients by analyzing a large sample of data from the Surveillance Epidemiology and End Results (SEER) database. Methods Data source and study population We used SEER*Stat 8.4.4 software to access the SEER cancer registries, which covered approximately 47.9% of the U.S. population. The inclusion criteria were as follows: (1) Year of diagnosis during 2000–2021; (2) Diagnosed with small cell lung cancer; (3) Age ≥ 70 years; (4) Stage at T1N0M0. We excluded cases with incomplete data, including unknown marital status, race, treatments (surgery, chemotherapy and radiotherapy), cancer-specific status, and survival time. Finally, this study enrolled a total of 1391 elderly patients with T1N0M0 SCLC (Fig. 1). Flow chart for inclusion and exclusion of patients with small cell lung cancer Study variables This study included the following variables: age at diagnosis (70–79, ≥ 80 years), sex (male, female), marital status (married, single, divorced or separated, and widowed), surgery (no, sublobar resection, lobectomy, and pneumonectomy), radiotherapy (yes, no), and chemotherapy (yes, no). Survival status included cancer-specific survival (CSS) and overall survival (OS). CSS was defined as the time between diagnosis and death due to small cell lung cancer, while OS was calculated as the time between diagnosis and death due to any cause. Statistical analysis All statistical analyses were performed using SPSS version 25.0. Categorical variables were compared using the Chi-square test. Survivals were performed with the Kaplan-Meier method, and compared using the log-rank test. Univariable and multivariable cox regression analysis was applied to identify the independent predictors of OS and CSS and calculate hazard ratios (HRs) with its 95% confidence interval. To balance differences in baseline clinical characteristics between the different marital status groups, we used a 1:1 propensity matching method (PSM) to reduce potential confounders in the study. All tests were two sided and a p-value < 0.05 was considered statistically significant. Results Patients’ characteristics Based on the inclusion and exclusion criteria, we identified 1391 elderly patients who were diagnosed with T1N0M0 SCLC between 2000 and 2021 in SEER database (Table 1). Of those, the majority of patients (71.5%) were 70–79 years old and 28.5% of patients were 80 years or older. 613 (44.1%) were male and 778 (55.9%) were female. Most patients were white (91.2%). There were 686 (49.3%) patients who were married, 113 (8.1%) patients who were single, 431 (31%) patients who were widowed and 161 (11.6%) patients who were divorced or separated. In addition, 333 (23.9%) underwent surgery (including sublobar resection, lobectomy and pneumonectomy), 804 (57.8%) received chemotherapy, and 764 (54.9%) treated with radiotherapy. Table 1Characteristics of patients at baselineCharacteristicsN = 1391Age, n (%)75–79995 (71.5%)≥ 80396 (28.5%)Sex, n (%)Male613 (44.1%)Female778 (55.9%)Race, n (%)White1268 (91.2%)Others123 (8.8%)Marital status, n (%)Married686 (49.3%)Single113 (8.1%)Widowed431 (31%)Divorced or separated161 (11.6%)Surgery, n (%)No1058 (76.1%)Sublobar resection154 (11.1%)Lobectomy174 (12.5%)Pneumonectomy5 (0.4%)Chemotherapy, n (%)No587 (42.2%)Yes804 (57.8%)Radiotherapy, n (%)No627 (45.1%)Yes764 (54.9%) Characteristics of patients at baseline Factors of OS in elderly T1N0M0 SCLC patients Table 2 shows the results of univariable and multivariable cox analysis of OS in elderly patients with T1N0M0 SCLC. In univariable analysis, factors that significantly influenced patients’ OS included age, gender, marital status, and receipt of surgery or chemotherapy (p < 0.05). In the multivariable cox analysis, widowed status (HR 1.224; 95% CI, 1.052–1.425; p = 0.009) was independently associated with worse OS, whereas female (HR 0.767; 95% CI 0.671–0.876; p < 0.001) was independently associated with better OS. Besides, the risk of death was significantly lower in patients who received sublobar resection (HR 0.657; 95% CI 0.541–0.798; p < 0.001) or lobectomy (HR 0.372; 95% CI 0.303–0.458; p < 0.001), and chemotherapy (HR 0.736; 95% CI 0.649–0.836; p < 0.001). Table 2Univariate and multivariate analysis for OS in elderly patients with T1N0M0 SCLCCharacteristicsUnivariate analysisMultivariate analysisHazard ratio (95% CI)P valueHazard ratio (95% CI)P valueAge 70–79ReferenceReference ≥ 801.351 (1.187–1.537)< 0.0011.091 (0.949–1.254)0.219Sex MaleReferenceReference Female0.820 (0.727–0.925)0.0010.767 (0.671–0.876)< 0.001Race WhiteReference Others0.975 (0.792–1.200)0.809Marital status MarriedReferenceReference Single1.045 (0.831–1.314)0.7061.082 (0.853–1.372)0.517 Widowed1.177 (1.028–1.348)0.0181.224 (1.052–1.425)0.009 Divorced or separated1.055 (0.867–1.284)0.5921.211 (0.990–1.483)0.063Surgery NoReferenceReference Sublobar resection0.650 (0.536–0.788)< 0.0010.657 (0.541–0.798)< 0.001 Lobectomy0.381 (0.311–0.466)< 0.0010.372 (0.303–0.458)< 0.001 Pneumonectomy0.978 (0.366–2.613)0.9641.041 (0.389–2.788)0.964Chemotherapy NoReferenceReference Yes0.773 (0.685–0.872)< 0.0010.736 (0.649–0.836)< 0.001Radiotherapy NoReference Yes0.896 (0.795–1.010)0.073 Univariate and multivariate analysis for OS in elderly patients with T1N0M0 SCLC Factors of CSS in elderly T1N0M0 SCLC patients Table 3 shows the results of univariable and multivariable cox analysis for CSS in elderly patients with T1N0M0 SCLC. In univariable analysis, age ≥ 80 years and widowed status significantly correlated with reduced CSS (p < 0.05), whereas receipt of surgery, chemotherapy and radiotherapy was statistically associated with better CSS (p < 0.05). In multivariate cox analysis, age ≥ 80 years (HR 1.194; 95% CI 1.014–1.407; p = 0.034), undergoing sublobar resection (HR 0.403; 95% CI 0.311–0.522; p < 0.001) or lobectomy (HR 0.221; 95% CI 0.166–0.294; p < 0.001), and receipt of chemotherapy (HR 0.839; 95% CI 0.718–0.979; p = 0.026) and radiotherapy (HR 0.500; 95% CI 0.425–0.588; p < 0.001) were independent predictors of CSS in elderly patients with T1N0M0 SCLC. Table 3Univariate and multivariate analysis for CSS in elderly patients with T1N0M0 SCLCCharacteristicsUnivariate analysisMultivariate analysisHazard ratio (95% CI)P valueHazard ratio (95% CI)P valueAge 70–79ReferenceReference ≥ 801.405 (1.206–1.638)< 0.0011.194 (1.014–1.407)0.034Sex MaleReference Female0.923 (0.798–1.067)0.281Race WhiteReference Others0.942 (0.731–1.215)0.647Marital status MarriedReferenceReference Single1.077 (0.819–1.416)0.5950.978 (0.743–1.287)0.873 Widowed1.248 (1.062–1.466)0.0071.117 (0.946–1.319)0.191 Divorced or separated1.003 (0.786–1.279)0.9831.073 (0.840–1.371)0.574Surgery NoReferenceReference Sublobar resection0.584 (0.458–0.744)< 0.0010.403 (0.311–0.522)< 0.001 Lobectomy0.330 (0.252–0.431)< 0.0010.221 (0.166–0.294)< 0.001 Pneumonectomy1.000 (0.321–3.112)1.0000.672 (0.214–2.108)0.496Chemotherapy NoReferenceReference Yes0.741 (0.641–0.856)< 0.0010.839 (0.718–0.979)0.026Radiotherapy NoReferenceReference Yes0.812 (0.703–0.937)0.0040.500 (0.425–0.588)< 0.001 Univariate and multivariate analysis for CSS in elderly patients with T1N0M0 SCLC Survival analysis between married and widowed patients before and after PSM We previously found that widowed patients had lower OS and CSS than married patients. To reduce selection bias in baseline characteristics between the married and widowed groups, we performed a 1:1 PSM analysis to balance the differences in age, gender, race, and whether or not the two groups received surgery, chemotherapy, and radiotherapy treatment. Baseline characteristics before and after the PSM are shown in Table 4. Before PSM matching, the widowed group had a significantly higher proportion of super-elderly (≥ 80 years) and female patients than the married group. In addition, married patients were more likely to receive surgery and chemotherapy. After matching, each group included 325 patients, and there were no differences between the two groups in age, gender, race, and whether or not they received surgery, chemotherapy, and radiotherapy (p > 0.05). The results of the Kaplan-Meier survival analysis showed that before PSM, the median OS and CSS were lower in widowed patients than in married patients. After PSM, similarly, the median OS in widowed patients (19 months; 95% CI, 16–22 months) was significantly lower than that in married patients (26 months; 95% CI, 21–34 months), and the median CSS in widowed patients (24 months; 95% CI, 21–28 months) was also lower than that in married patients (35 months; 95% CI, 28 − 41 months) (Fig. 2). Table 4Baseline characteristics of married or widowed patients with T1N0M0 SCLC before and after PSMCharacteristicsBefore PSMAfter PSMMarried(N = 686)Widowed(N = 431)P valueMarried(N = 325)Widowed(N = 325)P valueAge, n (%)< 0.0011.000 70–79531 (77.4%)243 (56.4%)243 (74.8%)243 (74.8%) ≥ 80155 (22.6%)188 (43.6%)82 (25.2%)82 (25.2%)Sex, n (%)< 0.0011.000 Male423 (61.7%)95 (22%)95 (29.2%)95 (29.2%) Female263 (38.3%)336 (78%)230 (70.8%)230 (70.8%)Race, n (%)0.9110.768 White629 (91.7%)396 (91.9%)301 (92.6%)299 (92%) Others57 (8.3%)35 (8.1%)24 (7.4%)26 (8%)Surgery, n (%)0.0270.403 No496 (72.3%)345 (80%)249 (76.6%)240 (73.8%) Sublobar resection91 (13.3%)42 (9.7%)36 (11.1%)41 (12.6%) Lobectomy97 (14.1%)42 (9.7%)38 (11.7%)44 (13.5%) Pneumonectomy2 (0.3%)2 (0.5%)2 (0.6%)0 (0%)Radiotherapy, n (%)0.4300.525 No319 (46.5%)190 (44.1%)132 (40.6%)140 (43.1%) Yes367 (53.5%)241 (55.9%)193 (59.4%)185 (56.9%)Chemotherapy, n (%)0.0020.302 No262 (38.2%)205 (47.6%)145 (44.6%)132 (40.6%) Yes424 (61.8%)226 (52.4%)180 (55.4%)193 (59.4%) Baseline characteristics of married or widowed patients with T1N0M0 SCLC before and after PSM Kaplan-Meier survival curves for overall survival in elderly SCLC patients before PSM (A) and after PSM (B). Kaplan-Meier survival curves for cancer-specific survival in elderly SCLC patients before PSM (C) and after PSM (D) Subgroup analysis of the impact of marital disparities on survival Subgroup analyses based on patients’ marital status were performed to elucidate the impact of marital differences on survival outcomes in different subgroups (Figs. 3 and 4). Compared to married patients, not all subgroups showed statistically significant differences, although widowed patients tended to have a higher risk of death in all subgroups. In the subgroup of patients aged 70–79 years, OS was significantly lower in widowed patients compared with married patients, but in the subgroup of patients aged ≥ 80 years, there was no significant difference in OS between these two groups. Subgroup analyses of the impact on overall survival in the married and widowed groups of patients Subgroup analyses of the impact on cancer-specific survival in the married and widowed groups of patients In the subgroup of male patients, both OS and CSS were significantly lower in widowed patients compared to married patients, but in the subgroup of female patients, there were no significant differences in OS and CSS between the two groups. In addition, stratified analyses were performed according to whether patients received surgery or radiotherapy. We found that in the group of patients who did not undergo surgery, the OS of widowed patients was lower than that of married patients. However, for the group of patients who underwent surgery, there was no statistical difference in OS between the widowed and married groups. Similarly, in the group of patients who did not receive radiotherapy, both OS and CSS were lower in widowed patients than in married patients, whereas for the group of patients who received radiotherapy, there was no statistically significant difference in OS and CSS between the widowed and married groups. Discussion Marital status is one of the important social factors that has gradually received widespread attention for its impact on cancer prognosis. Studies have also confirmed that marital status affects the prognosis of cancer patients [5, 6]. However, there are fewer studies on the effect of marital status on survival in elderly patients with early-stage SCLC. With the improvement of living standards and healthcare, human life expectancy is getting longer and the proportion of elderly tumour patients is increasing year by year. Therefore, the health problems of elderly patients with cancer should be emphasised. SCLC is highly aggressive and has a very poor prognosis, especially in elderly patients. Therefore, the aim of this study was to analyse the effect of marital status on the survival of elderly patients with early-stage SCLC through a large cohort population. Our study found that marital status is an important prognostic factor in elderly patients with T1N0M0 SCLC. Compared to married patients, widowed elderly patients had significantly lower survival. Marital status may affect patients' survival through its effect on treatment adherence [7]. A meta-analysis including 122 studies showed that married patients had higher treatment adherence [8]. Patients with lower treatment adherence have an increased risk of cancer deaths [9]. Secondly, married patients have more social support, mainly from their spouses [10], which can motivate the patient to actively cooperate with the treatment and positively influence the survival outcome [10]. In addition, marital status can affect prognosis by influencing patients’s psychological condition. Studies have shown that unmarried patients may experience more depression, anxiety and stress when faced with cancer, which may lead to disturbances in the immune system and promote tumour progression [11, 12]. In this study, we found that the proportion of patients receiving treatment (including surgery and chemotherapy) was higher in the married group than in the widowed group, suggesting that older married patients are more actively involved in treatment, which may contribute to better prognosis. To further clarify the effect of marital status on the prognosis of elderly patients, we also performed propensity matching analysis (PSM). Both before and after PSM, OS and CSS were higher in the married group than in the widowed group, suggesting that marital status may be able to directly influence the prognosis of elderly patients. Therefore, more social support should be given to elderly widowed patients. Many cancers show gender differences in prognosis [13]. Most studies have also observed that gender affects cancer survival [14, 15]. Gender differences affecting cancer survival are partly due to biological differences between male and female. Studies have shown that male and female have differences in immune system function, genes and hormones [16, 17]. In addition, differences in behavioural patterns and environmental factors between male and female also indirectly influence cancer survival [18]. Most studies show that men with cancer have a worse prognosis than women [19, 20]. Our study focused on elderly patients (≥ 70 years) and found that women had significantly higher survival than men, and multivariate analyses also confirmed gender as an independent prognostic factor in elderly SCLC patients. Then, we also performed subgroup analyses to analyse the effect of marital status on the prognosis of elderly patients in different subgroups. Among the elderly patients, married and widowed patients accounted for the major proportion. Therefore, we focused on analysing the prognostic differences in different subgroups between the married and widowed groups. We found differences in the impact of different genders on the survival of elderly patients with different marital status. Among male patients, the survival of widowed patients was significantly lower than that of married patients, but among female patients, there was no significant difference in survival between these two groups. We also found that among patients who were aged 70–79 years, the survival of widowed patients was significantly lower than that of married patients, but there was no significant difference in survival between the two groups when patients were aged ≥ 80 years. This phenomenon may be due to the fact that super-elderly patients were unable to receive treatment due to their poor physical condition, resulting in no significant difference in prognosis between the married and widowed groups. Our study also showed that in the group of patients who did not receive surgery or radiotherapy, the survival of the widowed patients was significantly lower than that of the married patients, however, for the patients who received surgery or radiotherapy, there was no statistically significant difference in the survival between the two groups. In summary, our study suggests that marital status is an important factor influencing survival in elderly patients with T1N0M0 SCLC. Compared to married elderly patients, survival was significantly lower in widowed patients, especially those who were 70–79 years old, male, and did not receive surgery or radiotherapy. Interventions to improve elderly widowed cancer patients can be based on a variety of aspects such as psychological support, life care, social activities and professional help. For example, providing more social and psychological support to elderly widowed patients may help to increase their positive emotions, thereby improving their adherence to treatment. Finally, the greatest strength of this study is that it is the first to analyse the impact of marital disparities on the treatment and prognosis of elderly patients with early-stage SCLC based on a large sample size, and to further clarify the difference in survival between married and widowed patients through propensity-matched analysis. Our study also has some limitations. First, our study data came from the SEER database and lacked an external independent cohort to further validate our core findings. Second, the SEER database lacks treatment-specific information on chemotherapy and radiotherapy. In addition, we were unable to obtain additional social factors that influence cancer prognosis, such as social and community environment and education level. Conclusion Our study demonstrated that marital status was an important factor influencing the survival of elderly T1N0M0 SCLC patients. Widowed patients had significantly lower survival rates compared to married patients, especially for those who were 70–79 years old, male, and who did not undergo surgery or radiotherapy. Therefore, social and psychological support may be needed for this group of elderly patients. Acknowledgements Not applicable. Authors’ contributions YHW, YJZ, NY and JHL designed the study. BD, RQJ, YPH, CLL, NY, and JPZ participated in data collection and analysis. YHW, YJZ and LHL performed data analysis and wrote the manuscript. All authors read and approved the final manuscript. Funding The study was supported by the Joint Funds for the Innovation of Science and Technology of Fujian Province (2018Y9063) and Fujian Provincial Natural Science Foundation of China (2024J01615) . Data availability The datasets used and/or analysed during the current study will be available from the corresponding author on reasonable request. Declarations Ethics approval and consent to participate All procedures described in this study were performed in accordance with the principles of the Declaration of Helsinki. Since data released by the SEER database was publicly available, ethics approval and informed patient consent was not required for this study. Consent for publication Not applicable. Competing interests The authors declare no competing interests. Footnotes Publisher’s Note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations. Yahua Wu, Yingjiao Zhu and Lihu Lu contributed equally to this work. Contributor Information Na Yao, Email: yaona81@163.com. Jinhuo Lai, Email: laijinhuo_fjxh@163.com. References Associated Data Data Availability Statement The datasets used and/or analysed during the current study will be available from the corresponding author on reasonable request.